Blood cancer develop when certain gene mutations block the normal maturation of stem cells in the bone marrow. Furthermore, it can compile and crowd out healthy cells. However, modern targeted therapies can help in identifying gene mutations. In addition, these can aid in stopping cancer growth and causing programmed death.
What is Blood Cancer?
Blood cancers typically start in the bone marrow and affect blood cell formation and functioning. Moreover, it can occur when the DNA mutations cause abnormal blood cells to multiply. In addition, these mutations can lead the body to stop fighting infections and bleeding. Also, the entire circulatory and immunologic networks are compromised with such systemic imbalance, needing specific modern therapies.
What are the types of blood cancers?
There are three different types of blood cancers. Also, each of these has a different malignancy origin. Moreover, each of them can cause different symptoms in patients. The types are as follows:
- Leukemias (Marrow and Blood)
- Lymphomas (Lymphatic System)
- Myelomas (Plasma Cells)
Common Symptoms of Blood Cancer
Many patients undergo symptoms due to blood cancer. Also, it can also cause abnormal blood cells to push away healthy cells inside the bone marrow. Moreover, it disrupts the production of oxygen-carrying red blood cells, infection-fighting white blood cells, and clotting platelets. On the other hand, patients can require targeted therapies to manage such symptoms.
There are certain symptoms, like:
Common symptoms
- Fatigue
- Weakness
- Shortness of breath
- Fevers
- Skin ulcers
- Nosebleeds
- Swelling
- Weight Loss
- Joint Pain
- Feeling of fullness
- Night Sweats
- Heavy menstrual cycles
The Importance of Targeted Therapy
Targeted therapy is vital for cancer treatments in the long term. Also, it can target specific mutations, proteins and surface antigens. Moreover, these can be unique to the cancer cells. However, if we compare chemotherapies, which kill all rapidly dividing cells. Then, targeted therapies are a safer option, as they spare the healthy cells.
What are the medicines for Blood Cancer?
There are different medicines which can target different therapies. Also, it can help in targeted therapy, immunotherapy and chemotherapy. Moreover, these medicines can also have certain side effects and symptoms. Yet, a doctor prescribed it with the right doses.
There are certain medicines, like:
Ponatinib
This medicine targets the BCR-ABL1 protein, which aids in the production of cancerous white blood cells. Furthermore, Ponatinib acts as a tyrosine kinase inhibitor and causes decreased cancer spread.
What are the different brands?
What are the benefits?
- Prevents disease progression
- Decrease tumor size
- Reduce cancer cells count
- Overcomes the T315I Mutation
What are the side effects?
There are certain side effects, like:
Common side effects
- Skin rash
- Dryness
- Itching
- Nausea
- Fatigue
- Diarrhea
- Headache
- Joint pain
- Anemia
- Swelling
Serious side effects
- Blood Clots
- Heart Failure
- Liver Damage
- Severe Bleeding
Venetoclax
The medicine is a targeted therapy which inhibits BCL-2 inhibitors. Moreover, Venetoclax can block cancer growth and progression inside the body.
What are the different brands?
What are the benefits?
- Decrease cancer load
- Lowers tumor size
- Reduce cancer progression
- Targeted action
- Overcomes High-Risk Genetic Deletions
What are the side effects?
There are certain side effects, like:
Common side effects
- Neutropenia
- Anemia
- Fatigue
- Headache
- Swelling
- Upper respiratory tract infections
- Cough
- Abdominal pain
Serious side effects
- Tumor Lysis Syndrome
- Infections
- Severe Decreases in Blood Counts
Daratumumab
The medicine is a targeted monoclonal antibody which binds to CD38 proteins. Moreover, after binding Daratumumab can mark the cancer cells. Therefore, this action can help the immune system to recognize and attack them.
What are the different brands?
- DARZALEX (100mg, 400mg, 1800mg)
What are the benefits?
- Lowers cancer progression
- Reduce cancer load
- Decrease tumor size
- Targeted action
- Prevents Myeloma Progression
What are the side effects?
There are certain side effects, like:
Common side effects
- Chills
- Fever
- Cough
- Nausea
- Dizziness
- Cold
- Sore throat
- Back Pain
- Fatigue
- High blood pressure
Serious side effects
- Severe Allergic Reactions
- Serious Infections
- Low Blood Counts
- Blood Transfusion problems
What are precision medicine and blood cancer care?
Precision medicine blocks certain ways which are the primary source for cancer growth. Moreover, it can include genetic mutations, proteins, pathways and chemical signaling. In addition, blood cancer care is dependent on different therapies or treatments. Also, these cancers are treated with cellular therapies, immunotherapy, stem cell transplants and radiation therapy.
The Future of Blood Cancer Treatment
Blood cancer treatment in the future focuses on chemotherapy-free regimens. In addition, it also focuses on:
- Next-Gen Cellular Therapies,
- Multi-Specific Antibodies
- Resistance-Bypassing Targeted Molecules
- Ultra-Sensitive Molecular Monitoring
- Time-Limited Regimes
Conclusion
Blood cancer is a type of cancer which affects the blood cells’ production. Also, it has three primary types, which are leukemia, lymphoma and myeloma. Moreover, to treat these cancers, doctors use different therapies. In addition, patients can undergo certain symptoms that should be monitored. Furthermore, different medicines can target mutations, proteins and chemical pathways to block cancer growth.
FAQs
How can blood cancer be treated with different treatments?
Doctors treat blood cancer with these therapies. However, modern treatments rely on targeted therapy, as it spares healthy cells and kills specific cancer cells.
Can we manage these side effects of medicine?
Yes, most of the side effects patients undergo during treatment leave. Moreover, when the medicine works, it can leave slowly.
References
- Sharma, R., Kumar, S., Kaushik, N., & Singh, B. (2025). Decoding the Mystery of Blood Cancer: Cause, Diagnosis, and Management. Current Cancer Therapy Reviews, 21(1), 40-53. https://www.benthamdirect.com/content/journals/cctr/10.2174/0115733947263279231114111550
- Adeyemi, S. A., Ngema, L. M., & Choonara, Y. E. (2025). Advances in targeted therapies and emerging strategies for blood cancer treatment. RSC Pharmaceutics, 2(5), 950-961. https://pubs.rsc.org/en/content/articlehtml/2025/pm/d5pm00090d
- Fardin, M. F., & Akter, M. (2021). Review on blood cancer and their types. J. Mol. Pharm. Regul. Aff, 3(1), 18-26. https://www.researchgate.net/profile/Md-Faysal-Fardin/publication/357792601_Review_on_Blood_Cancer_and_their_Types/links/61dfabd74e4aff4a6439b330/Review-on-Blood-Cancer-and-their-Types.pdf
- Thakur, C., Nayak, P., Mishra, V., Sharma, M., & Saraogi, G. K. (2021). Treating blood cancer with nanotechnology: A paradigm shift. In Nano Drug Delivery Strategies for the Treatment of Cancers (pp. 225-243). Academic Press. https://www.sciencedirect.com/science/chapter/edited-volume/abs/pii/B9780128197936000102
- Kaur, R., Bhardwaj, A., & Gupta, S. (2023). Cancer treatment therapies: traditional to modern approaches to combat cancers. Molecular biology reports, 50(11), 9663-9676. https://link.springer.com/article/10.1007/s11033-023-08809-3
